Although a recent study did not showed evidence of the influence of rare PALB2 missense mutations and breast cancer risk [34], we think that multifactorial analysis incorporating different approaches to obtain a final pathogenic probability, are required to assess the implication of each of these missense PALB2 variants. Here, PALB2 is linked to breast cancer.